Health‐related quality‐of‐life results from PALETTE: A randomized, double‐blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|17|2933-2941

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.17, 2015-09, pp. : 2933-2941

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 333-338

Karger

Access to resources Recommend Favorite

Chemotherapy for soft tissue sarcoma

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2952-2960

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is There an Indication for High-Dose Chemotherapy in the Treatment of Bone and Soft-Tissue Sarcoma?

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soft Tissue Sarcoma: An Update on Systemic Treatment Options for Patients with Advanced Disease

By  

Oncology Research and Treatment, Vol. 37, Iss. 6, 2014-04 ,pp. : 355-362

Karger

Access to resources Recommend Favorite